Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Ark Biosciences, a Shanghai biotech developing...
Hanmi Pharma of South Korea announced another blockbuster...
BeiGene, a Beijing novel cancer drug developer, received...
Fresenius Medical Care, a German company focused on renal...
Suzhou Connect Biopharma reported positive data from a...
CANbridge Life Sciences, a Beijing biopharma,...
Nuance Biotech of Shanghai has acquired an option from...
Luqa Pharmaceuticals, a China dermatological in-licensing...
Cocoon Networks, a startup China investment firm, has set...
Xizang Haisco Pharma led a $15 million Series D funding...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
